In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine.

In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine.
复制标题

DOI:
10.1016/j.yjmcc.2009.01.012
复制
发表时间:
2009-06
影响因子:
5
通讯作者:
Brookes, Paul S.
Brookes, Paul S.
中科院分区:
医学2区
文献类型:
--
作者:
Nadtochiy, Sergiy M.;Burwell, Lindsay S.;Ingraham, Christopher A.;Spencer, Cody M.;Friedman, Alan E.;Pinkert, Carl A.;Brookes, Paul S.

文献摘要

参考文献

被引文献

相似文献

可逆的S-亚硝化和线粒体复合物I的抑制是心肌保护的潜在机制,由缺血预处理(IPC),S-亚硝基硫醇和亚硝酸盐招募。以前,为了利用这一机制,开发了线粒体S-亚硝基化剂S-亚硝基-2-巯基丙酰甘氨酸(SNO-MPG),并保护灌注心脏和分离的心肌细胞免受缺血-再灌注(IR)损伤。在本研究中,采用小鼠左前降支冠状动脉(LAD)闭塞的IR损伤模型,以确定SNO-MPG在体内的保护作用。在闭塞前30分钟腹腔内给予1 mg/kg SNO-MPG,在闭塞30分钟加2或24小时再灌注后,显著减少心肌梗死并改善EKG参数。SNO-MPG的保护程度与IPC相同,并且在再灌注时给药时也具有明显的保护作用。线粒体蛋白S-亚硝基硫醇含量的增加,并抑制复合物I,这两个都被逆转后2小时。再灌注。最后,来自在复合物I NDUSF 4亚基中具有杂合突变的小鼠的心脏对SNO-MPG或IPC的保护是难治的,这表明能够可逆抑制的全功能复合物I对于心脏保护是至关重要的。总体而言,这些结果与线粒体S-亚硝化和复合物I抑制在IPC和SNO-MPG体内心脏保护机制中的作用一致。
The reversible S-nitrosation and inhibition of mitochondrial complex I is a potential mechanism of cardioprotection, recruited by ischemic preconditioning (IPC), S-nitrosothiols, and nitrite. Previously, to exploit this mechanism, the mitochondrial S-nitrosating agent S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) was developed, and protected perfused hearts and isolated cardiomyocytes against ischemia-reperfusion (IR) injury. In the present study, the murine left anterior descending coronary artery (LAD) occlusion model of IR injury was employed, to determine the protective efficacy of SNO-MPG in vivo. Intraperitoneal administration of 1 mg/kg SNO-MPG, 30 min. prior to occlusion, significantly reduced myocardial infarction and improved EKG parameters, following 30 min. occlusion plus 2 or 24 hr. reperfusion. SNO-MPG protected to the same degree as IPC, and notably was also protective when administered at reperfusion. Cardioprotection was accompanied by increased mitochondrial protein S-nitrosothiol content, and inhibition of complex I, both of which were reversed after 2 hr. reperfusion. Finally, hearts from mice harboring a heterozygous mutation in the complex I NDUSF4 subunit were refractory to protection by either SNO-MPG or IPC, suggesting that a fully functional complex I, capable of reversible inhibition is critical for cardioprotection. Overall, these results are consistent with a role for mitochondrial S-nitrosation and complex I inhibition in the cardioprotective mechanism of IPC and SNO-MPG in vivo.
DOI: 10.1016/j.cardiores.2005.11.004
发表时间: 2006-02-01
影响因子: 10.8
作者:
Hassouna, A;Loubani, M;Galiñanes, M
通讯作者: Galiñanes, M
DOI: 10.1161/01.res.0000031151.21145.59
发表时间: 2002-08-23
影响因子: 20.1
作者:
Chandler, MP;Stanley, WC;Sabbah, HN
通讯作者: Sabbah, HN
DOI: 10.1016/j.freeradbiomed.2008.06.021
发表时间: 2008-09-15
影响因子: 7.4
作者:
Dabkowski, Erinne R.;Williamson, Courtney L.;Hollander, John M.
通讯作者: Hollander, John M.
DOI: 10.1038/ncb851
发表时间: 2002-10-01
影响因子: 21.3
作者:
Haendeler, J;Hoffmann, J;Dimmeler, S
通讯作者: Dimmeler, S
DOI: 10.1161/circulationaha.106.675710
发表时间: 2007-04-10
期刊: CIRCULATION
影响因子: 37.8
作者:
Cohen, Michael V.;Yang, Xi-Ming;Downey, James M.
通讯作者: Downey, James M.